Results
Title

Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.

Authors

Hooper, Perry B.; Farberg, Aaron S.; Fitzgerald, Alison L.; Siegel, Jennifer J.; Rackley, Briana B.; Prasai, Anesh; Kurley, Sarah J.; Goldberg, Matthew S.; Litchman, Graham H.

Publication

Cancer Investigation, 2022, Vol 40, Issue 10, p911

ISSN

0735-7907

Publication type

Academic Journal

DOI

10.1080/07357907.2022.2116454